PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clinical trial NCT04556617 · TERMINATED
Trial details
- NCT number
- NCT04556617
- Sponsor
- Opna Bio LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2022-05-24
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.